Global Small Molecule Drug CDMO Supply, Demand and Key Producers, 2023-2029
The global Small Molecule Drug CDMO market size is expected to reach $ 42080 million by 2029, rising at a market growth of 5.6% CAGR during the forecast period (2023-2029).
A CDMO is a company dedicated to providing drug development and manufacturing services for the pharmaceutical and biotechnology industries. CDMO activities can broadly be divided into four fields: product development, manufacture of active pharmaceutical ingredients (API), manufacture of finished dosage forms (FDF) and pharma packaging.
This report studies the global Small Molecule Drug CDMO demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Small Molecule Drug CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Small Molecule Drug CDMO that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Small Molecule Drug CDMO total market, 2018-2029, (USD Million)
Global Small Molecule Drug CDMO total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Small Molecule Drug CDMO total market, key domestic companies and share, (USD Million)
Global Small Molecule Drug CDMO revenue by player and market share 2018-2023, (USD Million)
Global Small Molecule Drug CDMO total market by Type, CAGR, 2018-2029, (USD Million)
Global Small Molecule Drug CDMO total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Small Molecule Drug CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Catalent, Thermo Fisher Scientific, Samsung Biologics, Fareva, WuXi AppTech, WuXi Biologics, Siegfried and FUJIFILM Diosynth Biotechnologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Small Molecule Drug CDMO market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Small Molecule Drug CDMO Market, By Region:
1. How big is the global Small Molecule Drug CDMO market?
2. What is the demand of the global Small Molecule Drug CDMO market?
3. What is the year over year growth of the global Small Molecule Drug CDMO market?
4. What is the total value of the global Small Molecule Drug CDMO market?
5. Who are the major players in the global Small Molecule Drug CDMO market?
6. What are the growth factors driving the market demand?
A CDMO is a company dedicated to providing drug development and manufacturing services for the pharmaceutical and biotechnology industries. CDMO activities can broadly be divided into four fields: product development, manufacture of active pharmaceutical ingredients (API), manufacture of finished dosage forms (FDF) and pharma packaging.
This report studies the global Small Molecule Drug CDMO demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Small Molecule Drug CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Small Molecule Drug CDMO that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Small Molecule Drug CDMO total market, 2018-2029, (USD Million)
Global Small Molecule Drug CDMO total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Small Molecule Drug CDMO total market, key domestic companies and share, (USD Million)
Global Small Molecule Drug CDMO revenue by player and market share 2018-2023, (USD Million)
Global Small Molecule Drug CDMO total market by Type, CAGR, 2018-2029, (USD Million)
Global Small Molecule Drug CDMO total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Small Molecule Drug CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Catalent, Thermo Fisher Scientific, Samsung Biologics, Fareva, WuXi AppTech, WuXi Biologics, Siegfried and FUJIFILM Diosynth Biotechnologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Small Molecule Drug CDMO market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Small Molecule Drug CDMO Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- FDF CDMO
- Packaging CDMO
- Clinical CDMO
- Pharmaceutical Company
- Biotechnology Company
- Other
- Lonza
- Catalent
- Thermo Fisher Scientific
- Samsung Biologics
- Fareva
- WuXi AppTech
- WuXi Biologics
- Siegfried
- FUJIFILM Diosynth Biotechnologies
- Asymchem
- Pfizer CentreOne
- Delpharm
- Recipharm
- AGC Pharma Chemicals
- Boehringer Ingelheim
- Vetter
- Curia
- Aenova
- Porton
1. How big is the global Small Molecule Drug CDMO market?
2. What is the demand of the global Small Molecule Drug CDMO market?
3. What is the year over year growth of the global Small Molecule Drug CDMO market?
4. What is the total value of the global Small Molecule Drug CDMO market?
5. Who are the major players in the global Small Molecule Drug CDMO market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Small Molecule Drug CDMO Introduction
1.2 World Small Molecule Drug CDMO Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Small Molecule Drug CDMO Total Market by Region (by Headquarter Location)
1.3.1 World Small Molecule Drug CDMO Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Small Molecule Drug CDMO Market Size (2018-2029)
1.3.3 China Small Molecule Drug CDMO Market Size (2018-2029)
1.3.4 Europe Small Molecule Drug CDMO Market Size (2018-2029)
1.3.5 Japan Small Molecule Drug CDMO Market Size (2018-2029)
1.3.6 South Korea Small Molecule Drug CDMO Market Size (2018-2029)
1.3.7 ASEAN Small Molecule Drug CDMO Market Size (2018-2029)
1.3.8 India Small Molecule Drug CDMO Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Small Molecule Drug CDMO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Small Molecule Drug CDMO Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Small Molecule Drug CDMO Consumption Value (2018-2029)
2.2 World Small Molecule Drug CDMO Consumption Value by Region
2.2.1 World Small Molecule Drug CDMO Consumption Value by Region (2018-2023)
2.2.2 World Small Molecule Drug CDMO Consumption Value Forecast by Region (2024-2029)
2.3 United States Small Molecule Drug CDMO Consumption Value (2018-2029)
2.4 China Small Molecule Drug CDMO Consumption Value (2018-2029)
2.5 Europe Small Molecule Drug CDMO Consumption Value (2018-2029)
2.6 Japan Small Molecule Drug CDMO Consumption Value (2018-2029)
2.7 South Korea Small Molecule Drug CDMO Consumption Value (2018-2029)
2.8 ASEAN Small Molecule Drug CDMO Consumption Value (2018-2029)
2.9 India Small Molecule Drug CDMO Consumption Value (2018-2029)
3 WORLD SMALL MOLECULE DRUG CDMO COMPANIES COMPETITIVE ANALYSIS
3.1 World Small Molecule Drug CDMO Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Small Molecule Drug CDMO Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Small Molecule Drug CDMO in 2022
3.2.3 Global Concentration Ratios (CR8) for Small Molecule Drug CDMO in 2022
3.3 Small Molecule Drug CDMO Company Evaluation Quadrant
3.4 Small Molecule Drug CDMO Market: Overall Company Footprint Analysis
3.4.1 Small Molecule Drug CDMO Market: Region Footprint
3.4.2 Small Molecule Drug CDMO Market: Company Product Type Footprint
3.4.3 Small Molecule Drug CDMO Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Small Molecule Drug CDMO Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Small Molecule Drug CDMO Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Small Molecule Drug CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Small Molecule Drug CDMO Consumption Value Comparison
4.2.1 United States VS China: Small Molecule Drug CDMO Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Small Molecule Drug CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Small Molecule Drug CDMO Companies and Market Share, 2018-2023
4.3.1 United States Based Small Molecule Drug CDMO Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Small Molecule Drug CDMO Revenue, (2018-2023)
4.4 China Based Companies Small Molecule Drug CDMO Revenue and Market Share, 2018-2023
4.4.1 China Based Small Molecule Drug CDMO Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Small Molecule Drug CDMO Revenue, (2018-2023)
4.5 Rest of World Based Small Molecule Drug CDMO Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Small Molecule Drug CDMO Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Small Molecule Drug CDMO Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Small Molecule Drug CDMO Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 FDF CDMO
5.2.2 Packaging CDMO
5.2.3 Clinical CDMO
5.3 Market Segment by Type
5.3.1 World Small Molecule Drug CDMO Market Size by Type (2018-2023)
5.3.2 World Small Molecule Drug CDMO Market Size by Type (2024-2029)
5.3.3 World Small Molecule Drug CDMO Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Small Molecule Drug CDMO Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Company
6.2.2 Biotechnology Company
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Small Molecule Drug CDMO Market Size by Application (2018-2023)
6.3.2 World Small Molecule Drug CDMO Market Size by Application (2024-2029)
6.3.3 World Small Molecule Drug CDMO Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Lonza
7.1.1 Lonza Details
7.1.2 Lonza Major Business
7.1.3 Lonza Small Molecule Drug CDMO Product and Services
7.1.4 Lonza Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Lonza Recent Developments/Updates
7.1.6 Lonza Competitive Strengths & Weaknesses
7.2 Catalent
7.2.1 Catalent Details
7.2.2 Catalent Major Business
7.2.3 Catalent Small Molecule Drug CDMO Product and Services
7.2.4 Catalent Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Catalent Recent Developments/Updates
7.2.6 Catalent Competitive Strengths & Weaknesses
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Details
7.3.2 Thermo Fisher Scientific Major Business
7.3.3 Thermo Fisher Scientific Small Molecule Drug CDMO Product and Services
7.3.4 Thermo Fisher Scientific Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Thermo Fisher Scientific Recent Developments/Updates
7.3.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.4 Samsung Biologics
7.4.1 Samsung Biologics Details
7.4.2 Samsung Biologics Major Business
7.4.3 Samsung Biologics Small Molecule Drug CDMO Product and Services
7.4.4 Samsung Biologics Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Samsung Biologics Recent Developments/Updates
7.4.6 Samsung Biologics Competitive Strengths & Weaknesses
7.5 Fareva
7.5.1 Fareva Details
7.5.2 Fareva Major Business
7.5.3 Fareva Small Molecule Drug CDMO Product and Services
7.5.4 Fareva Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Fareva Recent Developments/Updates
7.5.6 Fareva Competitive Strengths & Weaknesses
7.6 WuXi AppTech
7.6.1 WuXi AppTech Details
7.6.2 WuXi AppTech Major Business
7.6.3 WuXi AppTech Small Molecule Drug CDMO Product and Services
7.6.4 WuXi AppTech Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 WuXi AppTech Recent Developments/Updates
7.6.6 WuXi AppTech Competitive Strengths & Weaknesses
7.7 WuXi Biologics
7.7.1 WuXi Biologics Details
7.7.2 WuXi Biologics Major Business
7.7.3 WuXi Biologics Small Molecule Drug CDMO Product and Services
7.7.4 WuXi Biologics Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 WuXi Biologics Recent Developments/Updates
7.7.6 WuXi Biologics Competitive Strengths & Weaknesses
7.8 Siegfried
7.8.1 Siegfried Details
7.8.2 Siegfried Major Business
7.8.3 Siegfried Small Molecule Drug CDMO Product and Services
7.8.4 Siegfried Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Siegfried Recent Developments/Updates
7.8.6 Siegfried Competitive Strengths & Weaknesses
7.9 FUJIFILM Diosynth Biotechnologies
7.9.1 FUJIFILM Diosynth Biotechnologies Details
7.9.2 FUJIFILM Diosynth Biotechnologies Major Business
7.9.3 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Product and Services
7.9.4 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
7.9.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
7.10 Asymchem
7.10.1 Asymchem Details
7.10.2 Asymchem Major Business
7.10.3 Asymchem Small Molecule Drug CDMO Product and Services
7.10.4 Asymchem Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Asymchem Recent Developments/Updates
7.10.6 Asymchem Competitive Strengths & Weaknesses
7.11 Pfizer CentreOne
7.11.1 Pfizer CentreOne Details
7.11.2 Pfizer CentreOne Major Business
7.11.3 Pfizer CentreOne Small Molecule Drug CDMO Product and Services
7.11.4 Pfizer CentreOne Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Pfizer CentreOne Recent Developments/Updates
7.11.6 Pfizer CentreOne Competitive Strengths & Weaknesses
7.12 Delpharm
7.12.1 Delpharm Details
7.12.2 Delpharm Major Business
7.12.3 Delpharm Small Molecule Drug CDMO Product and Services
7.12.4 Delpharm Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Delpharm Recent Developments/Updates
7.12.6 Delpharm Competitive Strengths & Weaknesses
7.13 Recipharm
7.13.1 Recipharm Details
7.13.2 Recipharm Major Business
7.13.3 Recipharm Small Molecule Drug CDMO Product and Services
7.13.4 Recipharm Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Recipharm Recent Developments/Updates
7.13.6 Recipharm Competitive Strengths & Weaknesses
7.14 AGC Pharma Chemicals
7.14.1 AGC Pharma Chemicals Details
7.14.2 AGC Pharma Chemicals Major Business
7.14.3 AGC Pharma Chemicals Small Molecule Drug CDMO Product and Services
7.14.4 AGC Pharma Chemicals Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 AGC Pharma Chemicals Recent Developments/Updates
7.14.6 AGC Pharma Chemicals Competitive Strengths & Weaknesses
7.15 Boehringer Ingelheim
7.15.1 Boehringer Ingelheim Details
7.15.2 Boehringer Ingelheim Major Business
7.15.3 Boehringer Ingelheim Small Molecule Drug CDMO Product and Services
7.15.4 Boehringer Ingelheim Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Boehringer Ingelheim Recent Developments/Updates
7.15.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.16 Vetter
7.16.1 Vetter Details
7.16.2 Vetter Major Business
7.16.3 Vetter Small Molecule Drug CDMO Product and Services
7.16.4 Vetter Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Vetter Recent Developments/Updates
7.16.6 Vetter Competitive Strengths & Weaknesses
7.17 Curia
7.17.1 Curia Details
7.17.2 Curia Major Business
7.17.3 Curia Small Molecule Drug CDMO Product and Services
7.17.4 Curia Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Curia Recent Developments/Updates
7.17.6 Curia Competitive Strengths & Weaknesses
7.18 Aenova
7.18.1 Aenova Details
7.18.2 Aenova Major Business
7.18.3 Aenova Small Molecule Drug CDMO Product and Services
7.18.4 Aenova Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Aenova Recent Developments/Updates
7.18.6 Aenova Competitive Strengths & Weaknesses
7.19 Porton
7.19.1 Porton Details
7.19.2 Porton Major Business
7.19.3 Porton Small Molecule Drug CDMO Product and Services
7.19.4 Porton Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Porton Recent Developments/Updates
7.19.6 Porton Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Small Molecule Drug CDMO Industry Chain
8.2 Small Molecule Drug CDMO Upstream Analysis
8.3 Small Molecule Drug CDMO Midstream Analysis
8.4 Small Molecule Drug CDMO Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Small Molecule Drug CDMO Introduction
1.2 World Small Molecule Drug CDMO Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Small Molecule Drug CDMO Total Market by Region (by Headquarter Location)
1.3.1 World Small Molecule Drug CDMO Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Small Molecule Drug CDMO Market Size (2018-2029)
1.3.3 China Small Molecule Drug CDMO Market Size (2018-2029)
1.3.4 Europe Small Molecule Drug CDMO Market Size (2018-2029)
1.3.5 Japan Small Molecule Drug CDMO Market Size (2018-2029)
1.3.6 South Korea Small Molecule Drug CDMO Market Size (2018-2029)
1.3.7 ASEAN Small Molecule Drug CDMO Market Size (2018-2029)
1.3.8 India Small Molecule Drug CDMO Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Small Molecule Drug CDMO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Small Molecule Drug CDMO Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Small Molecule Drug CDMO Consumption Value (2018-2029)
2.2 World Small Molecule Drug CDMO Consumption Value by Region
2.2.1 World Small Molecule Drug CDMO Consumption Value by Region (2018-2023)
2.2.2 World Small Molecule Drug CDMO Consumption Value Forecast by Region (2024-2029)
2.3 United States Small Molecule Drug CDMO Consumption Value (2018-2029)
2.4 China Small Molecule Drug CDMO Consumption Value (2018-2029)
2.5 Europe Small Molecule Drug CDMO Consumption Value (2018-2029)
2.6 Japan Small Molecule Drug CDMO Consumption Value (2018-2029)
2.7 South Korea Small Molecule Drug CDMO Consumption Value (2018-2029)
2.8 ASEAN Small Molecule Drug CDMO Consumption Value (2018-2029)
2.9 India Small Molecule Drug CDMO Consumption Value (2018-2029)
3 WORLD SMALL MOLECULE DRUG CDMO COMPANIES COMPETITIVE ANALYSIS
3.1 World Small Molecule Drug CDMO Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Small Molecule Drug CDMO Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Small Molecule Drug CDMO in 2022
3.2.3 Global Concentration Ratios (CR8) for Small Molecule Drug CDMO in 2022
3.3 Small Molecule Drug CDMO Company Evaluation Quadrant
3.4 Small Molecule Drug CDMO Market: Overall Company Footprint Analysis
3.4.1 Small Molecule Drug CDMO Market: Region Footprint
3.4.2 Small Molecule Drug CDMO Market: Company Product Type Footprint
3.4.3 Small Molecule Drug CDMO Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Small Molecule Drug CDMO Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Small Molecule Drug CDMO Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Small Molecule Drug CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Small Molecule Drug CDMO Consumption Value Comparison
4.2.1 United States VS China: Small Molecule Drug CDMO Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Small Molecule Drug CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Small Molecule Drug CDMO Companies and Market Share, 2018-2023
4.3.1 United States Based Small Molecule Drug CDMO Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Small Molecule Drug CDMO Revenue, (2018-2023)
4.4 China Based Companies Small Molecule Drug CDMO Revenue and Market Share, 2018-2023
4.4.1 China Based Small Molecule Drug CDMO Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Small Molecule Drug CDMO Revenue, (2018-2023)
4.5 Rest of World Based Small Molecule Drug CDMO Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Small Molecule Drug CDMO Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Small Molecule Drug CDMO Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Small Molecule Drug CDMO Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 FDF CDMO
5.2.2 Packaging CDMO
5.2.3 Clinical CDMO
5.3 Market Segment by Type
5.3.1 World Small Molecule Drug CDMO Market Size by Type (2018-2023)
5.3.2 World Small Molecule Drug CDMO Market Size by Type (2024-2029)
5.3.3 World Small Molecule Drug CDMO Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Small Molecule Drug CDMO Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Company
6.2.2 Biotechnology Company
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Small Molecule Drug CDMO Market Size by Application (2018-2023)
6.3.2 World Small Molecule Drug CDMO Market Size by Application (2024-2029)
6.3.3 World Small Molecule Drug CDMO Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Lonza
7.1.1 Lonza Details
7.1.2 Lonza Major Business
7.1.3 Lonza Small Molecule Drug CDMO Product and Services
7.1.4 Lonza Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Lonza Recent Developments/Updates
7.1.6 Lonza Competitive Strengths & Weaknesses
7.2 Catalent
7.2.1 Catalent Details
7.2.2 Catalent Major Business
7.2.3 Catalent Small Molecule Drug CDMO Product and Services
7.2.4 Catalent Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Catalent Recent Developments/Updates
7.2.6 Catalent Competitive Strengths & Weaknesses
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Details
7.3.2 Thermo Fisher Scientific Major Business
7.3.3 Thermo Fisher Scientific Small Molecule Drug CDMO Product and Services
7.3.4 Thermo Fisher Scientific Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Thermo Fisher Scientific Recent Developments/Updates
7.3.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.4 Samsung Biologics
7.4.1 Samsung Biologics Details
7.4.2 Samsung Biologics Major Business
7.4.3 Samsung Biologics Small Molecule Drug CDMO Product and Services
7.4.4 Samsung Biologics Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Samsung Biologics Recent Developments/Updates
7.4.6 Samsung Biologics Competitive Strengths & Weaknesses
7.5 Fareva
7.5.1 Fareva Details
7.5.2 Fareva Major Business
7.5.3 Fareva Small Molecule Drug CDMO Product and Services
7.5.4 Fareva Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Fareva Recent Developments/Updates
7.5.6 Fareva Competitive Strengths & Weaknesses
7.6 WuXi AppTech
7.6.1 WuXi AppTech Details
7.6.2 WuXi AppTech Major Business
7.6.3 WuXi AppTech Small Molecule Drug CDMO Product and Services
7.6.4 WuXi AppTech Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 WuXi AppTech Recent Developments/Updates
7.6.6 WuXi AppTech Competitive Strengths & Weaknesses
7.7 WuXi Biologics
7.7.1 WuXi Biologics Details
7.7.2 WuXi Biologics Major Business
7.7.3 WuXi Biologics Small Molecule Drug CDMO Product and Services
7.7.4 WuXi Biologics Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 WuXi Biologics Recent Developments/Updates
7.7.6 WuXi Biologics Competitive Strengths & Weaknesses
7.8 Siegfried
7.8.1 Siegfried Details
7.8.2 Siegfried Major Business
7.8.3 Siegfried Small Molecule Drug CDMO Product and Services
7.8.4 Siegfried Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Siegfried Recent Developments/Updates
7.8.6 Siegfried Competitive Strengths & Weaknesses
7.9 FUJIFILM Diosynth Biotechnologies
7.9.1 FUJIFILM Diosynth Biotechnologies Details
7.9.2 FUJIFILM Diosynth Biotechnologies Major Business
7.9.3 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Product and Services
7.9.4 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
7.9.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
7.10 Asymchem
7.10.1 Asymchem Details
7.10.2 Asymchem Major Business
7.10.3 Asymchem Small Molecule Drug CDMO Product and Services
7.10.4 Asymchem Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Asymchem Recent Developments/Updates
7.10.6 Asymchem Competitive Strengths & Weaknesses
7.11 Pfizer CentreOne
7.11.1 Pfizer CentreOne Details
7.11.2 Pfizer CentreOne Major Business
7.11.3 Pfizer CentreOne Small Molecule Drug CDMO Product and Services
7.11.4 Pfizer CentreOne Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Pfizer CentreOne Recent Developments/Updates
7.11.6 Pfizer CentreOne Competitive Strengths & Weaknesses
7.12 Delpharm
7.12.1 Delpharm Details
7.12.2 Delpharm Major Business
7.12.3 Delpharm Small Molecule Drug CDMO Product and Services
7.12.4 Delpharm Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Delpharm Recent Developments/Updates
7.12.6 Delpharm Competitive Strengths & Weaknesses
7.13 Recipharm
7.13.1 Recipharm Details
7.13.2 Recipharm Major Business
7.13.3 Recipharm Small Molecule Drug CDMO Product and Services
7.13.4 Recipharm Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Recipharm Recent Developments/Updates
7.13.6 Recipharm Competitive Strengths & Weaknesses
7.14 AGC Pharma Chemicals
7.14.1 AGC Pharma Chemicals Details
7.14.2 AGC Pharma Chemicals Major Business
7.14.3 AGC Pharma Chemicals Small Molecule Drug CDMO Product and Services
7.14.4 AGC Pharma Chemicals Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 AGC Pharma Chemicals Recent Developments/Updates
7.14.6 AGC Pharma Chemicals Competitive Strengths & Weaknesses
7.15 Boehringer Ingelheim
7.15.1 Boehringer Ingelheim Details
7.15.2 Boehringer Ingelheim Major Business
7.15.3 Boehringer Ingelheim Small Molecule Drug CDMO Product and Services
7.15.4 Boehringer Ingelheim Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Boehringer Ingelheim Recent Developments/Updates
7.15.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.16 Vetter
7.16.1 Vetter Details
7.16.2 Vetter Major Business
7.16.3 Vetter Small Molecule Drug CDMO Product and Services
7.16.4 Vetter Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Vetter Recent Developments/Updates
7.16.6 Vetter Competitive Strengths & Weaknesses
7.17 Curia
7.17.1 Curia Details
7.17.2 Curia Major Business
7.17.3 Curia Small Molecule Drug CDMO Product and Services
7.17.4 Curia Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Curia Recent Developments/Updates
7.17.6 Curia Competitive Strengths & Weaknesses
7.18 Aenova
7.18.1 Aenova Details
7.18.2 Aenova Major Business
7.18.3 Aenova Small Molecule Drug CDMO Product and Services
7.18.4 Aenova Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Aenova Recent Developments/Updates
7.18.6 Aenova Competitive Strengths & Weaknesses
7.19 Porton
7.19.1 Porton Details
7.19.2 Porton Major Business
7.19.3 Porton Small Molecule Drug CDMO Product and Services
7.19.4 Porton Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Porton Recent Developments/Updates
7.19.6 Porton Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Small Molecule Drug CDMO Industry Chain
8.2 Small Molecule Drug CDMO Upstream Analysis
8.3 Small Molecule Drug CDMO Midstream Analysis
8.4 Small Molecule Drug CDMO Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Small Molecule Drug CDMO Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Small Molecule Drug CDMO Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Small Molecule Drug CDMO Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Small Molecule Drug CDMO Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Small Molecule Drug CDMO Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Small Molecule Drug CDMO Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Small Molecule Drug CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Small Molecule Drug CDMO Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Small Molecule Drug CDMO Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Small Molecule Drug CDMO Players in 2022
Table 12. World Small Molecule Drug CDMO Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Small Molecule Drug CDMO Company Evaluation Quadrant
Table 14. Head Office of Key Small Molecule Drug CDMO Player
Table 15. Small Molecule Drug CDMO Market: Company Product Type Footprint
Table 16. Small Molecule Drug CDMO Market: Company Product Application Footprint
Table 17. Small Molecule Drug CDMO Mergers & Acquisitions Activity
Table 18. United States VS China Small Molecule Drug CDMO Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Small Molecule Drug CDMO Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Small Molecule Drug CDMO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Small Molecule Drug CDMO Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Small Molecule Drug CDMO Revenue Market Share (2018-2023)
Table 23. China Based Small Molecule Drug CDMO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Small Molecule Drug CDMO Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Small Molecule Drug CDMO Revenue Market Share (2018-2023)
Table 26. Rest of World Based Small Molecule Drug CDMO Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Small Molecule Drug CDMO Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Small Molecule Drug CDMO Revenue Market Share (2018-2023)
Table 29. World Small Molecule Drug CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Small Molecule Drug CDMO Market Size by Type (2018-2023) & (USD Million)
Table 31. World Small Molecule Drug CDMO Market Size by Type (2024-2029) & (USD Million)
Table 32. World Small Molecule Drug CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Small Molecule Drug CDMO Market Size by Application (2018-2023) & (USD Million)
Table 34. World Small Molecule Drug CDMO Market Size by Application (2024-2029) & (USD Million)
Table 35. Lonza Basic Information, Area Served and Competitors
Table 36. Lonza Major Business
Table 37. Lonza Small Molecule Drug CDMO Product and Services
Table 38. Lonza Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Lonza Recent Developments/Updates
Table 40. Lonza Competitive Strengths & Weaknesses
Table 41. Catalent Basic Information, Area Served and Competitors
Table 42. Catalent Major Business
Table 43. Catalent Small Molecule Drug CDMO Product and Services
Table 44. Catalent Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Catalent Recent Developments/Updates
Table 46. Catalent Competitive Strengths & Weaknesses
Table 47. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 48. Thermo Fisher Scientific Major Business
Table 49. Thermo Fisher Scientific Small Molecule Drug CDMO Product and Services
Table 50. Thermo Fisher Scientific Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Thermo Fisher Scientific Recent Developments/Updates
Table 52. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 53. Samsung Biologics Basic Information, Area Served and Competitors
Table 54. Samsung Biologics Major Business
Table 55. Samsung Biologics Small Molecule Drug CDMO Product and Services
Table 56. Samsung Biologics Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Samsung Biologics Recent Developments/Updates
Table 58. Samsung Biologics Competitive Strengths & Weaknesses
Table 59. Fareva Basic Information, Area Served and Competitors
Table 60. Fareva Major Business
Table 61. Fareva Small Molecule Drug CDMO Product and Services
Table 62. Fareva Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Fareva Recent Developments/Updates
Table 64. Fareva Competitive Strengths & Weaknesses
Table 65. WuXi AppTech Basic Information, Area Served and Competitors
Table 66. WuXi AppTech Major Business
Table 67. WuXi AppTech Small Molecule Drug CDMO Product and Services
Table 68. WuXi AppTech Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. WuXi AppTech Recent Developments/Updates
Table 70. WuXi AppTech Competitive Strengths & Weaknesses
Table 71. WuXi Biologics Basic Information, Area Served and Competitors
Table 72. WuXi Biologics Major Business
Table 73. WuXi Biologics Small Molecule Drug CDMO Product and Services
Table 74. WuXi Biologics Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. WuXi Biologics Recent Developments/Updates
Table 76. WuXi Biologics Competitive Strengths & Weaknesses
Table 77. Siegfried Basic Information, Area Served and Competitors
Table 78. Siegfried Major Business
Table 79. Siegfried Small Molecule Drug CDMO Product and Services
Table 80. Siegfried Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Siegfried Recent Developments/Updates
Table 82. Siegfried Competitive Strengths & Weaknesses
Table 83. FUJIFILM Diosynth Biotechnologies Basic Information, Area Served and Competitors
Table 84. FUJIFILM Diosynth Biotechnologies Major Business
Table 85. FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Product and Services
Table 86. FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 88. FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 89. Asymchem Basic Information, Area Served and Competitors
Table 90. Asymchem Major Business
Table 91. Asymchem Small Molecule Drug CDMO Product and Services
Table 92. Asymchem Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Asymchem Recent Developments/Updates
Table 94. Asymchem Competitive Strengths & Weaknesses
Table 95. Pfizer CentreOne Basic Information, Area Served and Competitors
Table 96. Pfizer CentreOne Major Business
Table 97. Pfizer CentreOne Small Molecule Drug CDMO Product and Services
Table 98. Pfizer CentreOne Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Pfizer CentreOne Recent Developments/Updates
Table 100. Pfizer CentreOne Competitive Strengths & Weaknesses
Table 101. Delpharm Basic Information, Area Served and Competitors
Table 102. Delpharm Major Business
Table 103. Delpharm Small Molecule Drug CDMO Product and Services
Table 104. Delpharm Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Delpharm Recent Developments/Updates
Table 106. Delpharm Competitive Strengths & Weaknesses
Table 107. Recipharm Basic Information, Area Served and Competitors
Table 108. Recipharm Major Business
Table 109. Recipharm Small Molecule Drug CDMO Product and Services
Table 110. Recipharm Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Recipharm Recent Developments/Updates
Table 112. Recipharm Competitive Strengths & Weaknesses
Table 113. AGC Pharma Chemicals Basic Information, Area Served and Competitors
Table 114. AGC Pharma Chemicals Major Business
Table 115. AGC Pharma Chemicals Small Molecule Drug CDMO Product and Services
Table 116. AGC Pharma Chemicals Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. AGC Pharma Chemicals Recent Developments/Updates
Table 118. AGC Pharma Chemicals Competitive Strengths & Weaknesses
Table 119. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 120. Boehringer Ingelheim Major Business
Table 121. Boehringer Ingelheim Small Molecule Drug CDMO Product and Services
Table 122. Boehringer Ingelheim Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Boehringer Ingelheim Recent Developments/Updates
Table 124. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 125. Vetter Basic Information, Area Served and Competitors
Table 126. Vetter Major Business
Table 127. Vetter Small Molecule Drug CDMO Product and Services
Table 128. Vetter Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Vetter Recent Developments/Updates
Table 130. Vetter Competitive Strengths & Weaknesses
Table 131. Curia Basic Information, Area Served and Competitors
Table 132. Curia Major Business
Table 133. Curia Small Molecule Drug CDMO Product and Services
Table 134. Curia Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Curia Recent Developments/Updates
Table 136. Curia Competitive Strengths & Weaknesses
Table 137. Aenova Basic Information, Area Served and Competitors
Table 138. Aenova Major Business
Table 139. Aenova Small Molecule Drug CDMO Product and Services
Table 140. Aenova Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Aenova Recent Developments/Updates
Table 142. Porton Basic Information, Area Served and Competitors
Table 143. Porton Major Business
Table 144. Porton Small Molecule Drug CDMO Product and Services
Table 145. Porton Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 146. Global Key Players of Small Molecule Drug CDMO Upstream (Raw Materials)
Table 147. Small Molecule Drug CDMO Typical Customers
Table 1. World Small Molecule Drug CDMO Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Small Molecule Drug CDMO Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Small Molecule Drug CDMO Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Small Molecule Drug CDMO Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Small Molecule Drug CDMO Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Small Molecule Drug CDMO Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Small Molecule Drug CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Small Molecule Drug CDMO Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Small Molecule Drug CDMO Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Small Molecule Drug CDMO Players in 2022
Table 12. World Small Molecule Drug CDMO Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Small Molecule Drug CDMO Company Evaluation Quadrant
Table 14. Head Office of Key Small Molecule Drug CDMO Player
Table 15. Small Molecule Drug CDMO Market: Company Product Type Footprint
Table 16. Small Molecule Drug CDMO Market: Company Product Application Footprint
Table 17. Small Molecule Drug CDMO Mergers & Acquisitions Activity
Table 18. United States VS China Small Molecule Drug CDMO Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Small Molecule Drug CDMO Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Small Molecule Drug CDMO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Small Molecule Drug CDMO Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Small Molecule Drug CDMO Revenue Market Share (2018-2023)
Table 23. China Based Small Molecule Drug CDMO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Small Molecule Drug CDMO Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Small Molecule Drug CDMO Revenue Market Share (2018-2023)
Table 26. Rest of World Based Small Molecule Drug CDMO Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Small Molecule Drug CDMO Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Small Molecule Drug CDMO Revenue Market Share (2018-2023)
Table 29. World Small Molecule Drug CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Small Molecule Drug CDMO Market Size by Type (2018-2023) & (USD Million)
Table 31. World Small Molecule Drug CDMO Market Size by Type (2024-2029) & (USD Million)
Table 32. World Small Molecule Drug CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Small Molecule Drug CDMO Market Size by Application (2018-2023) & (USD Million)
Table 34. World Small Molecule Drug CDMO Market Size by Application (2024-2029) & (USD Million)
Table 35. Lonza Basic Information, Area Served and Competitors
Table 36. Lonza Major Business
Table 37. Lonza Small Molecule Drug CDMO Product and Services
Table 38. Lonza Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Lonza Recent Developments/Updates
Table 40. Lonza Competitive Strengths & Weaknesses
Table 41. Catalent Basic Information, Area Served and Competitors
Table 42. Catalent Major Business
Table 43. Catalent Small Molecule Drug CDMO Product and Services
Table 44. Catalent Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Catalent Recent Developments/Updates
Table 46. Catalent Competitive Strengths & Weaknesses
Table 47. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 48. Thermo Fisher Scientific Major Business
Table 49. Thermo Fisher Scientific Small Molecule Drug CDMO Product and Services
Table 50. Thermo Fisher Scientific Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Thermo Fisher Scientific Recent Developments/Updates
Table 52. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 53. Samsung Biologics Basic Information, Area Served and Competitors
Table 54. Samsung Biologics Major Business
Table 55. Samsung Biologics Small Molecule Drug CDMO Product and Services
Table 56. Samsung Biologics Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Samsung Biologics Recent Developments/Updates
Table 58. Samsung Biologics Competitive Strengths & Weaknesses
Table 59. Fareva Basic Information, Area Served and Competitors
Table 60. Fareva Major Business
Table 61. Fareva Small Molecule Drug CDMO Product and Services
Table 62. Fareva Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Fareva Recent Developments/Updates
Table 64. Fareva Competitive Strengths & Weaknesses
Table 65. WuXi AppTech Basic Information, Area Served and Competitors
Table 66. WuXi AppTech Major Business
Table 67. WuXi AppTech Small Molecule Drug CDMO Product and Services
Table 68. WuXi AppTech Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. WuXi AppTech Recent Developments/Updates
Table 70. WuXi AppTech Competitive Strengths & Weaknesses
Table 71. WuXi Biologics Basic Information, Area Served and Competitors
Table 72. WuXi Biologics Major Business
Table 73. WuXi Biologics Small Molecule Drug CDMO Product and Services
Table 74. WuXi Biologics Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. WuXi Biologics Recent Developments/Updates
Table 76. WuXi Biologics Competitive Strengths & Weaknesses
Table 77. Siegfried Basic Information, Area Served and Competitors
Table 78. Siegfried Major Business
Table 79. Siegfried Small Molecule Drug CDMO Product and Services
Table 80. Siegfried Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Siegfried Recent Developments/Updates
Table 82. Siegfried Competitive Strengths & Weaknesses
Table 83. FUJIFILM Diosynth Biotechnologies Basic Information, Area Served and Competitors
Table 84. FUJIFILM Diosynth Biotechnologies Major Business
Table 85. FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Product and Services
Table 86. FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 88. FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 89. Asymchem Basic Information, Area Served and Competitors
Table 90. Asymchem Major Business
Table 91. Asymchem Small Molecule Drug CDMO Product and Services
Table 92. Asymchem Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Asymchem Recent Developments/Updates
Table 94. Asymchem Competitive Strengths & Weaknesses
Table 95. Pfizer CentreOne Basic Information, Area Served and Competitors
Table 96. Pfizer CentreOne Major Business
Table 97. Pfizer CentreOne Small Molecule Drug CDMO Product and Services
Table 98. Pfizer CentreOne Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Pfizer CentreOne Recent Developments/Updates
Table 100. Pfizer CentreOne Competitive Strengths & Weaknesses
Table 101. Delpharm Basic Information, Area Served and Competitors
Table 102. Delpharm Major Business
Table 103. Delpharm Small Molecule Drug CDMO Product and Services
Table 104. Delpharm Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Delpharm Recent Developments/Updates
Table 106. Delpharm Competitive Strengths & Weaknesses
Table 107. Recipharm Basic Information, Area Served and Competitors
Table 108. Recipharm Major Business
Table 109. Recipharm Small Molecule Drug CDMO Product and Services
Table 110. Recipharm Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Recipharm Recent Developments/Updates
Table 112. Recipharm Competitive Strengths & Weaknesses
Table 113. AGC Pharma Chemicals Basic Information, Area Served and Competitors
Table 114. AGC Pharma Chemicals Major Business
Table 115. AGC Pharma Chemicals Small Molecule Drug CDMO Product and Services
Table 116. AGC Pharma Chemicals Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. AGC Pharma Chemicals Recent Developments/Updates
Table 118. AGC Pharma Chemicals Competitive Strengths & Weaknesses
Table 119. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 120. Boehringer Ingelheim Major Business
Table 121. Boehringer Ingelheim Small Molecule Drug CDMO Product and Services
Table 122. Boehringer Ingelheim Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Boehringer Ingelheim Recent Developments/Updates
Table 124. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 125. Vetter Basic Information, Area Served and Competitors
Table 126. Vetter Major Business
Table 127. Vetter Small Molecule Drug CDMO Product and Services
Table 128. Vetter Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Vetter Recent Developments/Updates
Table 130. Vetter Competitive Strengths & Weaknesses
Table 131. Curia Basic Information, Area Served and Competitors
Table 132. Curia Major Business
Table 133. Curia Small Molecule Drug CDMO Product and Services
Table 134. Curia Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Curia Recent Developments/Updates
Table 136. Curia Competitive Strengths & Weaknesses
Table 137. Aenova Basic Information, Area Served and Competitors
Table 138. Aenova Major Business
Table 139. Aenova Small Molecule Drug CDMO Product and Services
Table 140. Aenova Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Aenova Recent Developments/Updates
Table 142. Porton Basic Information, Area Served and Competitors
Table 143. Porton Major Business
Table 144. Porton Small Molecule Drug CDMO Product and Services
Table 145. Porton Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 146. Global Key Players of Small Molecule Drug CDMO Upstream (Raw Materials)
Table 147. Small Molecule Drug CDMO Typical Customers
LIST OF FIGURES
Figure 1. Small Molecule Drug CDMO Picture
Figure 2. World Small Molecule Drug CDMO Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Small Molecule Drug CDMO Total Market Size (2018-2029) & (USD Million)
Figure 4. World Small Molecule Drug CDMO Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Small Molecule Drug CDMO Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Small Molecule Drug CDMO Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Small Molecule Drug CDMO Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Small Molecule Drug CDMO Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Small Molecule Drug CDMO Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Small Molecule Drug CDMO Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Small Molecule Drug CDMO Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Small Molecule Drug CDMO Revenue (2018-2029) & (USD Million)
Figure 13. Small Molecule Drug CDMO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 16. World Small Molecule Drug CDMO Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 18. China Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 23. India Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Small Molecule Drug CDMO by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Small Molecule Drug CDMO Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Small Molecule Drug CDMO Markets in 2022
Figure 27. United States VS China: Small Molecule Drug CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Small Molecule Drug CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Small Molecule Drug CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Small Molecule Drug CDMO Market Size Market Share by Type in 2022
Figure 31. FDF CDMO
Figure 32. Packaging CDMO
Figure 33. Clinical CDMO
Figure 34. World Small Molecule Drug CDMO Market Size Market Share by Type (2018-2029)
Figure 35. World Small Molecule Drug CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Small Molecule Drug CDMO Market Size Market Share by Application in 2022
Figure 37. Pharmaceutical Company
Figure 38. Biotechnology Company
Figure 39. Other
Figure 40. Small Molecule Drug CDMO Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Figure 1. Small Molecule Drug CDMO Picture
Figure 2. World Small Molecule Drug CDMO Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Small Molecule Drug CDMO Total Market Size (2018-2029) & (USD Million)
Figure 4. World Small Molecule Drug CDMO Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Small Molecule Drug CDMO Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Small Molecule Drug CDMO Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Small Molecule Drug CDMO Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Small Molecule Drug CDMO Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Small Molecule Drug CDMO Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Small Molecule Drug CDMO Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Small Molecule Drug CDMO Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Small Molecule Drug CDMO Revenue (2018-2029) & (USD Million)
Figure 13. Small Molecule Drug CDMO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 16. World Small Molecule Drug CDMO Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 18. China Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 23. India Small Molecule Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Small Molecule Drug CDMO by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Small Molecule Drug CDMO Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Small Molecule Drug CDMO Markets in 2022
Figure 27. United States VS China: Small Molecule Drug CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Small Molecule Drug CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Small Molecule Drug CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Small Molecule Drug CDMO Market Size Market Share by Type in 2022
Figure 31. FDF CDMO
Figure 32. Packaging CDMO
Figure 33. Clinical CDMO
Figure 34. World Small Molecule Drug CDMO Market Size Market Share by Type (2018-2029)
Figure 35. World Small Molecule Drug CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Small Molecule Drug CDMO Market Size Market Share by Application in 2022
Figure 37. Pharmaceutical Company
Figure 38. Biotechnology Company
Figure 39. Other
Figure 40. Small Molecule Drug CDMO Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
